Research In Progress

Feb 10, 2019 | BALTIMORE –  Complete Omics and UMBC announced a collaboration to leverage our unique expertise in multi-omics diagnostics for a continuous education and training of UMBC students. 

Mar 29, 2020 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with, MSKCC, a world leader in cancer care on a variety of molecular diagnostics projects.

Aug 19, 2020 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with MD Anderson on a variety of molecular diagnostics projects.

Feb 10, 2021 | BALTIMORE –  Complete Omics’ Clinical Metabolomics team announced a collaboration with Dr. Renyuan Bai and Dr.  in Johns Hopkins Medicine on a series of metabolomics targeted detection projects.

April 21, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Ludwig Cancer Research Center on a series of clinical proteomics projects.

April 26, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Frame Cancer Therapeutics, an Amsterdam pharmaceutical company,  on a series of clinical proteomics projects.

May 4, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Grünenthal, a pharmaceutical company headquartered in Aachen in Germany, on a series of clinical single-cell based proteomics projects.

May 10, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Zhenghe Wang and his team from the Case Western Researve University on a series of clinical proteomics projects focusing on leveraging our Complete360 targete detection pipeline for biological discoveries.

June 4, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Sun Shi-yong lab in the Winship Cancer Institute of Emory University.

June 16, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Yonghong Wan’s lab at McMaster University at Hamilton Ontario Canada.

June 20, 2021 | BALTIMORE –  Complete Omics’ announced a collaboration with ErVaccine Technologies, a pharmaceutical company headquartered in Lyon, Rhone-Alpes, Francey, on a neoantigen validation and quantification project.

June 25, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Arvinas (Nasdaq:ARVN), a pharmaceutical company inventing the famous proprietary PROTAC® protein degraders.

July 10, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Christian S. Hinrichs from Rutgers Cancer Institute of New Jersey. 

July 15, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Benjamin Vincent from The University of North Carolina, on neoantigen-related projects.

July 16th, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Prof. Dr. Roland Schüle from University Medical Center Freiburg, the teaching hospital of the University of Freiburg.

July 18, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Yiping He from Duke University on a series of grants focusing on leveraging our labeling-dependent large scale quantitative proteomics assays for biological discoveries.

Aug 30, 2021 | BALTIMORE –  Complete Omics’ Clinical Genomics team announced a collaboration with Professor Ching-shuen Wang from Taipei Medical University on a series of RNA-seq projects leveraging our DEEPER-SeqS clinical genomics assays for biological discoveries from hard-to-sequence clinical samples.

Sept 16, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Dianqing (Dan) Wu from Yale University on a series of quantitative proteomics focusing on leveraging our clinical quantitative proteomics assays for biological discoveries.

Nov 10, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Patrick S. Moore and his team from University of Pittsburgh on a series of clinical proteomics projects focusing on leveraging our neoantigen quantification assays for biological discoveries.

Nov 15, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Netherlands Cancer Institute on a series of quantitative phosphoproteomics projects.

Nov 19, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Generate Biomedicines on a series of immunopeptidomics projects. On Nov 18 2021, Generate Biomedicines just announced a Series B financing of $370 million to advance its protein-targeted drug generation platform.

Dec 10, 2021 | BALTIMORE –  Complete Omics’ Clinical Genomics team announced a collaboration with Dr. Rebecca Morris on several single cell omics analysis projects

Jan 12, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Marco Sardiello and his team from Washington University in St. Louis on a clinical proteomics project focusing on using Complete360 platform for identifying novel biological mechanisms.

Jan 19, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Andras Attila Heczey and his team from Baylor College of Medicine on a clinical proteomics project focusing on leveraging our Complete360 body fluid proteomics assays for clinical discoveries.

Feb 07, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Sumati Gupta and her team from University of Utah Huntsman Cancer Institute on a clinical proteomics project focusing on leveraging our Complete360 proteomics assays for clinical discoveries.

Feb 26, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Luis Marques da Costa and his team from Lisbon School of Medicine on a clinical proteomics project focusing on leveraging our Complete360 body fluid proteomics assays for clinical discoveries.

Mar 20, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Miguel Weil from Department of Cell Research and Immunology at the Tel Aviv University on a clinical proteomics project focusing on leveraging our Complete360 body fluid proteomics assays for clinical discoveries.

Mar 30, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Kam W. Leong, Samuel Y. Sheng professor of Biomedical Engineering, and his team from Columbia University on a clinical proteomics project focusing on leveraging our Complete360 quantitative proteomics assays for clinical discoveries.